A finalized Medicare payment model for chemotherapy is not much of an improvement from its draft version, according to the American Society of Clinica... More »
Effective immediately, Medicare will cover annual lung cancer screening with low-dose CT for certain beneficiaries, according to a Feb. 5 national cov... More »
Gilead Sciences Inc. scored an exclusive deal with CVS Health Corp., as its two hepatitis C medicines, Harvoni and Sovaldi, will be available only for CVS customers.
Sovaldi costs $84,000 for a...
The Centers for Medicare & Medicaid Services has begun the process of considering coverage of screening for cervical cancer with human papillomavirus testing.
The agency announced Nov. 25 it has...
Medicare patients who are at high risk for lung cancer would be able to get screening using low-dose computed tomography under a proposed national coverage decision announced Nov. 10.
“The evidence...
New treatments for hepatitis C could boost federal spending for the Medicare Part D program by up to $5.8 billion in 2015 and lead to a 4.3%-8.6% premium increase for beneficiaries, according to a...